Silencing of PRDM5 increases cell proliferation and inhibits cell apoptosis in glioma

References

• Braunstein S, Raleigh D, Bindra R, et al. Pediatric high-grade glioma: current molecular landscape and therapeutic approaches. J Neurooncol. 2017;134(3):541–549.
   PubMed Web of Science ®Google Scholar
• Eyler CE, Wu Q, Yan K, et al. Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2. Cell. 2011;146(1):53–66.
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–996.
   PubMed Web of Science ®Google Scholar
• Kim RK, Suh Y, Cui YH, et al. Fractionated radiation-induced nitric oxide promotes expansion of glioma stem-like cells. Cancer Sci. 2013;104(9):1172–1177.
   PubMed Web of Science ®Google Scholar
• van Dijken BRJ, van Laar PJ, Holtman GA, et al. Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and meta-analysis. Eur Radiol. 2017;27(10):4129–4144.
   PubMed Web of Science ®Google Scholar
• Bauer R, Kaiser M, Stoll E. A computational model incorporating neural stem cell dynamics reproduces glioma incidence across the lifespan in the human population. PLoS One. 2014;9(11):e111219.
   PubMed Web of Science ®Google Scholar
• Sharma M, Juthani RG, Vogelbaum MA. Updated response assessment criteria for high-grade glioma: beyond the MacDonald criteria. Chin Clin Oncol. 2017;6(4):37–37.
   PubMed Web of Science ®Google Scholar
• Xia S, Lal B, Tung B, et al. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation. Neuro Oncol. 2016;18(4):507–517.
   PubMed Web of Science ®Google Scholar
• Cheng HY, Chen XW, Cheng L, et al. DNA methylation and carcinogenesis of PRDM5 in cervical cancer. J Cancer Res Clin Oncol. 2010;136(12):1821–1825.
   PubMed Web of Science ®Google Scholar
• Deng Q, Huang S. PRDM5 is silenced in human cancers and has growth suppressive activities. Oncogene. 2004;23(28):4903–4910.
   PubMed Web of Science ®Google Scholar
• Ding HL, Clouthier DE, Artinger KB. Redundant roles of PRDM family members in zebrafish craniofacial development. Dev Dyn. 2013;242(1):67–79.
   PubMed Web of Science ®Google Scholar
• Shu XS, Geng H, Li L, et al. The epigenetic modifier PRDM5 functions as a tumor suppressor through modulating WNT/beta-catenin signaling and is frequently silenced in multiple tumors. PLoS One. 2011;6(11):e27346.
   PubMed Web of Science ®Google Scholar
• Tan SX, Hu RC, Liu JJ, et al. Methylation of PRDM2, PRDM5 and PRDM16 genes in lung cancer cells. Int J Clin Exp Pathol. 2014;7(5):2305–2311.
   PubMed Web of Science ®Google Scholar
• Tan SX, Hu RC, Tan YL, et al. Promoter methylation-mediated downregulation of PRDM5 contributes to the development of lung squamous cell carcinoma. Tumor Biol. 2014;35(5):4509–4516.
   PubMedGoogle Scholar
• Watanabe Y, Kim HS, Castoro RJ, et al. Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes. Gastroenterology. 2009;136(7):2149–2158.
   PubMed Web of Science ®Google Scholar
• Duan Z, Person RE, Lee HH, et al. Epigenetic regulation of protein-coding and microRNA genes by the Gfi1-interacting tumor suppressor PRDM5. Mol Cell Biol. 2007;27(19):6889–6902.
   PubMed Web of Science ®Google Scholar
• Xia J, Zhou Y, Ji H, et al. Loss of histone deacetylases 1 and 2 in hepatocytes impairs murine liver regeneration through Ki67 depletion. Hepatology. 2013;58(6):2089–2098.
   PubMed Web of Science ®Google Scholar
• Meani N, Pezzimenti F, Deflorian G, et al. The tumor suppressor PRDM5 regulates Wnt signaling at early stages of zebrafish development. PLoS One. 2009;4(1):e4273.
   PubMed Web of Science ®Google Scholar
• Tanaka S, Louis DN, Curry WT, et al. Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? Nat Rev Clin Oncol. 2013;10(1):14–26.
   PubMed Web of Science ®Google Scholar
• Chen J, McKay RM, Parada LF. Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell. 2012;149(1):36–47.
   PubMed Web of Science ®Google Scholar
• Huse JT, Holland E, DeAngelis LM. Glioblastoma: molecular analysis and clinical implications. Annu Rev Med. 2013;64(1):59–70.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu F, Mao F, et al. Interaction with cyclin H/cyclin-dependent kinase 7 (CCNH/CDK7) stabilizes C-terminal binding protein 2 (CtBP2) and promotes cancer cell migration. J Biol Chem. 2013;288(13):9028–9034.
   PubMed Web of Science ®Google Scholar
• Ding Z, Liu Y, Yao L, et al. Spy1 induces de-ubiquitinating of RIP1 arrest and confers glioblastoma’s resistance to tumor necrosis factor (TNF-alpha)-induced apoptosis through suppressing the association of CLIPR-59 and CYLD. Cell Cycle. 2015;14(13):2149–2159.
   PubMed Web of Science ®Google Scholar
• Eyupoglu IY, Buchfelder M, Savaskan NE. Surgical resection of malignant gliomas-role in optimizing patient outcome. Nat Rev Neurol. 2013;9:141–151.
   PubMed Web of Science ®Google Scholar
• Tao T, Cheng C, Ji Y, et al. Numbl inhibits glioma cell migration and invasion by suppressing TRAF5-mediated NF-kappaB activation. MBoC. 2012;23(14):2635–2644.
   Web of Science ®Google Scholar
• Galli GG, Carrara M, Francavilla C, et al. Genomic and proteomic analyses of Prdm5 reveal interactions with insulator binding proteins in embryonic stem cells. Mol Cell Biol. 2013;33(22):4504–4516.
   PubMed Web of Science ®Google Scholar
• Galli GG, Multhaupt HA, Carrara M, et al. Prdm5 suppresses Apc(Min)-driven intestinal adenomas and regulates monoacylglycerol lipase expression. Oncogene. 2014;33(25):3342–3350.
   PubMed Web of Science ®Google Scholar
• Wu H, Wang L, Zhang D, et al. PRDM5 promotes the apoptosis of epithelial cells induced by IFN-gamma during Crohn’s disease. Pathol Res Pract. 2017;213(6):666–673.
   PubMed Web of Science ®Google Scholar
• Zhang H, Li D, Zhang Y, et al. Knockdown of lncRNA BDNF-AS suppresses neuronal cell apoptosis via downregulating miR-130b-5p target gene PRDM5 in acute spinal cord injury. RNA Biol. 2018;15:1071–1080.
   PubMed Web of Science ®Google Scholar
• Chang RM, Xu JF, Fang F, et al. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1alpha signaling. Tumor Biol. 2016;37(8):10609–10619.
   PubMedGoogle Scholar
• Chen H, Yang Y, Wang J, et al. miR-130b-5p promotes proliferation, migration and invasion of gastric cancer cells via targeting RASAL1. Oncol Lett. 2018;15:6361–6367.
   PubMed Web of Science ®Google Scholar